- Home
- TIL vs GLDG Comparison
TIL vs GLDG Comparison
Compare TIL & GLDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- GLDG
- Stock Information
- Founded
- TIL 2018
- GLDG 2009
- Country
- TIL United States
- GLDG Canada
- Employees
- TIL N/A
- GLDG N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- GLDG Precious Metals
- Sector
- TIL Health Care
- GLDG Basic Materials
- Exchange
- TIL Nasdaq
- GLDG Nasdaq
- Market Cap
- TIL 171.7M
- GLDG 157.0M
- IPO Year
- TIL 2021
- GLDG N/A
- Fundamental
- Price
- TIL $17.21
- GLDG $0.84
- Analyst Decision
- TIL Buy
- GLDG Strong Buy
- Analyst Count
- TIL 5
- GLDG 1
- Target Price
- TIL $114.00
- GLDG $3.25
- AVG Volume (30 Days)
- TIL 85.6K
- GLDG 533.8K
- Earning Date
- TIL 03-04-2025
- GLDG 04-11-2025
- Dividend Yield
- TIL N/A
- GLDG N/A
- EPS Growth
- TIL N/A
- GLDG N/A
- EPS
- TIL N/A
- GLDG N/A
- Revenue
- TIL N/A
- GLDG N/A
- Revenue This Year
- TIL N/A
- GLDG N/A
- Revenue Next Year
- TIL N/A
- GLDG N/A
- P/E Ratio
- TIL N/A
- GLDG N/A
- Revenue Growth
- TIL N/A
- GLDG N/A
- 52 Week Low
- TIL $9.62
- GLDG $0.75
- 52 Week High
- TIL $92.00
- GLDG $1.06
- Technical
- Relative Strength Index (RSI)
- TIL 42.69
- GLDG 51.96
- Support Level
- TIL $17.87
- GLDG $0.81
- Resistance Level
- TIL $19.61
- GLDG $0.85
- Average True Range (ATR)
- TIL 1.68
- GLDG 0.03
- MACD
- TIL -0.06
- GLDG -0.00
- Stochastic Oscillator
- TIL 5.69
- GLDG 26.64
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About GLDG GoldMining Inc.
GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia, Crucero project, located in Peru, Sao Jorge, Batistao, Boa Vista, located in Brazil, Yellowknife Gold Project, located in the Northwest Territories, Canada, and other projects. The company earns maximum revenue from Canada.